Development of treatment for HER2 or EGFR exon 20 insertion mutation-driven NSCLC

被引：0
|
作者：
Ninomiya, Kiichiro [1 ]
机构：
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.478
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY20-3
引用
收藏
页码：S444 / S444
页数：1
相关论文
共 50 条
  • [41] Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations
    Bazhenova, L.
    Yang, J. Chih-Hsin
    Wang, M.
    Mitchell, P.
    Camidge, D. Ross
    Fang, J.
    Nian, W.
    Chiu, C. -H.
    Zhou, J.
    Zhao, Y.
    Su, W. -C.
    Yang, T. -Y.
    Zhu, V. W.
    Millward, M.
    Fan, Y.
    Huang, W. -T.
    Cheng, Y.
    Jiang, L.
    Zheng, L.
    Janne, P. A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E3 - E3
  • [42] Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations: Effect of Prior Treatment
    Yang, J. C. -H.
    Wang, M.
    Mitchell, P.
    Fang, J.
    Nian, W.
    Chiu, C-H.
    Zhou, J.
    Zhao, Y.
    Su, W. -C.
    Camidge, R.
    Yang, T. -Y.
    Zhu, V.
    Millward, M.
    Fan, Y.
    Huang, W. -T.
    Cheng, Y.
    Jiang, L.
    Brungs, D.
    Bazhenova, L. B.
    Lee, C. K.
    Gao, B.
    Zheng, L.
    Janne, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S410 - S411
  • [43] Safety, PK, and Preliminary Antitumor Activity of the Oral EGFR/HER2 Exon 20 Inhibitor TAK-788 in NSCLC
    Neal, J.
    Doebele, R.
    Riely, G.
    Spira, A.
    Horn, L.
    Piotrowska, Z.
    Costa, D.
    Zhang, S.
    Bottino, D.
    Zhu, J.
    Kerstein, D.
    Li, S.
    Janne, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S599 - S599
  • [44] SUCCESSFUL SUNVOZERTINIB RECHALLENGE FOR ADVANCED LUNG ADENOCARCINOMA WITH HER2 EXON20 INSERTION MUTATION: A CASE REPORT
    Guan, Wenhui
    Jiang, Huixin
    Cao, Jingjing
    Su, Zhihao
    Wu, Ying
    Lin, Xinqing
    Zhou, Chengzhi
    CHEST, 2024, 166 (04) : 4218A - 4219A
  • [45] Efficacy and Safety of Poziotinib in HER2 Exon 20 Insertion NSCLC Patients who Received at Least 2 Previous Systemic Therapies
    Le, X.
    Prelaj, A.
    Baik, C.
    Tchekmedyian, N.
    Leu, S.
    Bhat, G.
    Heymach, J. V.
    Cornelissen, R.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S147 - S148
  • [46] JIN-A04, highly effective tyrosine kinase inhibitor targeting HER2 exon 20 insertion mutations in NSCLC
    Yu, Mi Ra
    Yun, Mi Ran
    Lee, Jii Bum
    Lee, Ji Yun
    Aum, So Won
    Choi, Su Jin
    Park, Ju Yeon
    Oh, Seung Yeon
    Lee, Eun Ji
    Duggirala, Krishna Babu
    Lee, Kwangho
    Hong, Min Hee
    Lim, Sun Min
    Jo, Anna
    Seah, Ethan
    Kim, Choonok
    Cho, Byoung Chul
    CANCER RESEARCH, 2023, 83 (07)
  • [47] TY-4028: a novel, targeted therapy for non small-cell lung cancer with EGFR exon 20 or HER2 exon 20 insertion mutations
    Li, Jun
    Niu, Chengshan
    Guo, Zhongwei
    Wang, Huan
    Zheng, Bailu
    Dou, Yuge
    Liang, Apeng
    Ji, Kaige
    Dong, Shengli
    Li, Meihua
    Zhao, Yanchao
    Zhang, Yazhen
    Gong, Aishen
    Liu, Hao
    Hu, Xinmiao
    Su, Hui
    Jiang, Mingyu
    Chen, Shaoqing
    Chen, Xiugui
    Wu, Yusheng
    CANCER RESEARCH, 2023, 83 (07)
  • [48] JNJ-61186372, an EGFR-cMet Bispecific Antibody, in EGFR Exon 20 Insertion-Driven Advanced NSCLC
    Yun, J.
    Kang, H. N.
    Lee, S.
    Park, C.
    Jeong, S.
    Hong, M. H.
    Kim, H. R.
    Thayu, M.
    Curtin, J. C.
    Knoblauch, R. E.
    Lorenzi, M. V.
    Roshak, A.
    Cho, B. C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S397 - S398
  • [49] Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation
    Zoechbauer-Mueller, Sabine
    Kaserer, Bettina
    Prosch, Helmut
    Cseh, Agnieszka
    Solca, Flavio
    Bauer, Markus Johann
    Muellauer, Leonhard
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [50] Clinical outcomes of EGFR exon 20 insertion in advanced NSCLC in Korea.
    Byeon, Seonggyu
    Kim, Youjin
    Lee, Jiyun
    Sun, Jong-Mu
    Choi, Yoon-La
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345